Regarding paracetamol, we intentionally used higher than usual doses to maximise its likely benefi cial eff ects. By contrast with use of paracetamol in adult patients, its use is safe in children beyond the neonatal age, and there is no evidence to suggest that a daily dose lower than 100 mg/kg for a few days would be substantially hepatotoxic or otherwise harmful; 2,3 our anaesthesiologists have used higher doses for many years without problems.
We agree that in a resourcepoor setting infusion is not equal in ease of use to the traditional bolus administration. However, this fact should be put into perspective. Mortality associated with bacterial meningitis has not decreased sub stantially since the advent of chlor am phenicol and lower doses (10-15 mg/kg) to safeguard against hepatotoxicity. 4 Practically, use of infusions in resource-constraint settings is less feasible than bolus administration and can potentially delay initiation of timely antimicrobial treatment in such serious illnesses.
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